IGF2 in memory, neurodevelopmental disorders, and neurodegenerative diseases

Insulin-like growth factor 2 (IGF2) plays a critical role in memory and cognition in adult rodents, whereas its alterations contribute to CNS diseases. Yet, the mechanisms by which IGF2 is involved in these processes are unclear.In rodents, IGF2 administration promotes memory enhancement and persist...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Trends in neurosciences (Regular ed.) 2023-06, Vol.46 (6), p.488-502
1. Verfasser: Alberini, Cristina M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 502
container_issue 6
container_start_page 488
container_title Trends in neurosciences (Regular ed.)
container_volume 46
creator Alberini, Cristina M.
description Insulin-like growth factor 2 (IGF2) plays a critical role in memory and cognition in adult rodents, whereas its alterations contribute to CNS diseases. Yet, the mechanisms by which IGF2 is involved in these processes are unclear.In rodents, IGF2 administration promotes memory enhancement and persistence. IGF2 administration restores impaired memory functions in aged rats and reverses cognitive impairments and several other deficits in rodent models of neurodevelopmental and neurodegenerative disorders.The beneficial effects of IGF2 occur via its high-affinity receptor, the IGF2 receptor (IGF2R), which may represent a target for potential therapeutic development.Current knowledge of IGF2R-mediated mechanisms in both heathy brains and diseases remains limited. Here, I propose a conceptual model for these mechanisms in which IGF2 or other IGF2R ligands promote vesicle network communications and protein metabolism quality control. This framework may explain how treatments based on IGF2R ligands could counteract diseases characterized by protein accumulation in the brain. Insulin-like growth factor 2 (IGF2) emerged as a critical mechanism of synaptic plasticity and learning and memory. Deficits in IGF2 in the brain, serum, or cerebrospinal fluid (CSF) are associated with brain diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), and amyotrophic lateral sclerosis (ALS). Increasing IGF2 levels enhances memory in healthy animals and reverses numerous symptoms in laboratory models of aging, neurodevelopmental disorders, and neurodegenerative diseases. These effects occur via the IGF2 receptor (IGF2R) – a receptor that is highly expressed in neurons and regulates protein trafficking, synthesis, and degradation. Here, I summarize the current knowledge regarding IGF2 expression and functions in the brain, particularly in memory, and propose a novel conceptual model for IGF2/IGF2R mechanisms of action in brain health and diseases.
doi_str_mv 10.1016/j.tins.2023.03.007
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2798713423</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0166223623000693</els_id><sourcerecordid>2798713423</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-7c4d8679188fac6932ad39542a2323f8595fe31bfa059beca0d5f1ec6a17586d3</originalsourceid><addsrcrecordid>eNp9kE1LAzEURYMotlb_gAuZpYvO-JLMTDLgRoqthYIbBXchTd5IynzUZKbQf--Uti6FC29z7oV3CLmnkFCg-dMm6VwTEgaMJzAExAUZUylkTEF-XZLxAOUxYzwfkZsQNgA0lTS9JiMugFPIYExWy8WcRa6Jaqxbv59GDfa-tbjDqt3W2HS6iqwLrbfowzTSjT0T39ig153b4QFAHTDckqtSVwHvTndCPuevH7O3ePW-WM5eVrFJAbpYmNTKXBRUylKbvOBMW15kKdOMM17KrMhK5HRdasiKNRoNNispmlxTkcnc8gl5PO5uffvTY-hU7YLBqtINtn1QTBRSUJ4yPqDsiBrfhuCxVFvvau33ioI6WFQbdbCoDhYVDAExlB5O-_26RvtXOWsbgOcjgMOXO4deBeOwMWidR9Mp27r_9n8BhVCDrg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2798713423</pqid></control><display><type>article</type><title>IGF2 in memory, neurodevelopmental disorders, and neurodegenerative diseases</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Alberini, Cristina M.</creator><creatorcontrib>Alberini, Cristina M.</creatorcontrib><description>Insulin-like growth factor 2 (IGF2) plays a critical role in memory and cognition in adult rodents, whereas its alterations contribute to CNS diseases. Yet, the mechanisms by which IGF2 is involved in these processes are unclear.In rodents, IGF2 administration promotes memory enhancement and persistence. IGF2 administration restores impaired memory functions in aged rats and reverses cognitive impairments and several other deficits in rodent models of neurodevelopmental and neurodegenerative disorders.The beneficial effects of IGF2 occur via its high-affinity receptor, the IGF2 receptor (IGF2R), which may represent a target for potential therapeutic development.Current knowledge of IGF2R-mediated mechanisms in both heathy brains and diseases remains limited. Here, I propose a conceptual model for these mechanisms in which IGF2 or other IGF2R ligands promote vesicle network communications and protein metabolism quality control. This framework may explain how treatments based on IGF2R ligands could counteract diseases characterized by protein accumulation in the brain. Insulin-like growth factor 2 (IGF2) emerged as a critical mechanism of synaptic plasticity and learning and memory. Deficits in IGF2 in the brain, serum, or cerebrospinal fluid (CSF) are associated with brain diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), and amyotrophic lateral sclerosis (ALS). Increasing IGF2 levels enhances memory in healthy animals and reverses numerous symptoms in laboratory models of aging, neurodevelopmental disorders, and neurodegenerative diseases. These effects occur via the IGF2 receptor (IGF2R) – a receptor that is highly expressed in neurons and regulates protein trafficking, synthesis, and degradation. Here, I summarize the current knowledge regarding IGF2 expression and functions in the brain, particularly in memory, and propose a novel conceptual model for IGF2/IGF2R mechanisms of action in brain health and diseases.</description><identifier>ISSN: 0166-2236</identifier><identifier>EISSN: 1878-108X</identifier><identifier>DOI: 10.1016/j.tins.2023.03.007</identifier><identifier>PMID: 37031050</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Alzheimer Disease ; Animals ; Brain - metabolism ; cation-independent mannose 6 phosphate receptor ; Humans ; IGF2 receptor ; memory ; neurodegenerative disease ; Neurodegenerative Diseases - metabolism ; neurodevelopmental disorder ; Neurodevelopmental Disorders ; Parkinson Disease ; protein metabolism</subject><ispartof>Trends in neurosciences (Regular ed.), 2023-06, Vol.46 (6), p.488-502</ispartof><rights>2023 Elsevier Ltd</rights><rights>Copyright © 2023 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-7c4d8679188fac6932ad39542a2323f8595fe31bfa059beca0d5f1ec6a17586d3</citedby><cites>FETCH-LOGICAL-c400t-7c4d8679188fac6932ad39542a2323f8595fe31bfa059beca0d5f1ec6a17586d3</cites><orcidid>0000-0001-7386-0018</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0166223623000693$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37031050$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alberini, Cristina M.</creatorcontrib><title>IGF2 in memory, neurodevelopmental disorders, and neurodegenerative diseases</title><title>Trends in neurosciences (Regular ed.)</title><addtitle>Trends Neurosci</addtitle><description>Insulin-like growth factor 2 (IGF2) plays a critical role in memory and cognition in adult rodents, whereas its alterations contribute to CNS diseases. Yet, the mechanisms by which IGF2 is involved in these processes are unclear.In rodents, IGF2 administration promotes memory enhancement and persistence. IGF2 administration restores impaired memory functions in aged rats and reverses cognitive impairments and several other deficits in rodent models of neurodevelopmental and neurodegenerative disorders.The beneficial effects of IGF2 occur via its high-affinity receptor, the IGF2 receptor (IGF2R), which may represent a target for potential therapeutic development.Current knowledge of IGF2R-mediated mechanisms in both heathy brains and diseases remains limited. Here, I propose a conceptual model for these mechanisms in which IGF2 or other IGF2R ligands promote vesicle network communications and protein metabolism quality control. This framework may explain how treatments based on IGF2R ligands could counteract diseases characterized by protein accumulation in the brain. Insulin-like growth factor 2 (IGF2) emerged as a critical mechanism of synaptic plasticity and learning and memory. Deficits in IGF2 in the brain, serum, or cerebrospinal fluid (CSF) are associated with brain diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), and amyotrophic lateral sclerosis (ALS). Increasing IGF2 levels enhances memory in healthy animals and reverses numerous symptoms in laboratory models of aging, neurodevelopmental disorders, and neurodegenerative diseases. These effects occur via the IGF2 receptor (IGF2R) – a receptor that is highly expressed in neurons and regulates protein trafficking, synthesis, and degradation. Here, I summarize the current knowledge regarding IGF2 expression and functions in the brain, particularly in memory, and propose a novel conceptual model for IGF2/IGF2R mechanisms of action in brain health and diseases.</description><subject>Alzheimer Disease</subject><subject>Animals</subject><subject>Brain - metabolism</subject><subject>cation-independent mannose 6 phosphate receptor</subject><subject>Humans</subject><subject>IGF2 receptor</subject><subject>memory</subject><subject>neurodegenerative disease</subject><subject>Neurodegenerative Diseases - metabolism</subject><subject>neurodevelopmental disorder</subject><subject>Neurodevelopmental Disorders</subject><subject>Parkinson Disease</subject><subject>protein metabolism</subject><issn>0166-2236</issn><issn>1878-108X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LAzEURYMotlb_gAuZpYvO-JLMTDLgRoqthYIbBXchTd5IynzUZKbQf--Uti6FC29z7oV3CLmnkFCg-dMm6VwTEgaMJzAExAUZUylkTEF-XZLxAOUxYzwfkZsQNgA0lTS9JiMugFPIYExWy8WcRa6Jaqxbv59GDfa-tbjDqt3W2HS6iqwLrbfowzTSjT0T39ig153b4QFAHTDckqtSVwHvTndCPuevH7O3ePW-WM5eVrFJAbpYmNTKXBRUylKbvOBMW15kKdOMM17KrMhK5HRdasiKNRoNNispmlxTkcnc8gl5PO5uffvTY-hU7YLBqtINtn1QTBRSUJ4yPqDsiBrfhuCxVFvvau33ioI6WFQbdbCoDhYVDAExlB5O-_26RvtXOWsbgOcjgMOXO4deBeOwMWidR9Mp27r_9n8BhVCDrg</recordid><startdate>202306</startdate><enddate>202306</enddate><creator>Alberini, Cristina M.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7386-0018</orcidid></search><sort><creationdate>202306</creationdate><title>IGF2 in memory, neurodevelopmental disorders, and neurodegenerative diseases</title><author>Alberini, Cristina M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-7c4d8679188fac6932ad39542a2323f8595fe31bfa059beca0d5f1ec6a17586d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Alzheimer Disease</topic><topic>Animals</topic><topic>Brain - metabolism</topic><topic>cation-independent mannose 6 phosphate receptor</topic><topic>Humans</topic><topic>IGF2 receptor</topic><topic>memory</topic><topic>neurodegenerative disease</topic><topic>Neurodegenerative Diseases - metabolism</topic><topic>neurodevelopmental disorder</topic><topic>Neurodevelopmental Disorders</topic><topic>Parkinson Disease</topic><topic>protein metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alberini, Cristina M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Trends in neurosciences (Regular ed.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alberini, Cristina M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>IGF2 in memory, neurodevelopmental disorders, and neurodegenerative diseases</atitle><jtitle>Trends in neurosciences (Regular ed.)</jtitle><addtitle>Trends Neurosci</addtitle><date>2023-06</date><risdate>2023</risdate><volume>46</volume><issue>6</issue><spage>488</spage><epage>502</epage><pages>488-502</pages><issn>0166-2236</issn><eissn>1878-108X</eissn><abstract>Insulin-like growth factor 2 (IGF2) plays a critical role in memory and cognition in adult rodents, whereas its alterations contribute to CNS diseases. Yet, the mechanisms by which IGF2 is involved in these processes are unclear.In rodents, IGF2 administration promotes memory enhancement and persistence. IGF2 administration restores impaired memory functions in aged rats and reverses cognitive impairments and several other deficits in rodent models of neurodevelopmental and neurodegenerative disorders.The beneficial effects of IGF2 occur via its high-affinity receptor, the IGF2 receptor (IGF2R), which may represent a target for potential therapeutic development.Current knowledge of IGF2R-mediated mechanisms in both heathy brains and diseases remains limited. Here, I propose a conceptual model for these mechanisms in which IGF2 or other IGF2R ligands promote vesicle network communications and protein metabolism quality control. This framework may explain how treatments based on IGF2R ligands could counteract diseases characterized by protein accumulation in the brain. Insulin-like growth factor 2 (IGF2) emerged as a critical mechanism of synaptic plasticity and learning and memory. Deficits in IGF2 in the brain, serum, or cerebrospinal fluid (CSF) are associated with brain diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), and amyotrophic lateral sclerosis (ALS). Increasing IGF2 levels enhances memory in healthy animals and reverses numerous symptoms in laboratory models of aging, neurodevelopmental disorders, and neurodegenerative diseases. These effects occur via the IGF2 receptor (IGF2R) – a receptor that is highly expressed in neurons and regulates protein trafficking, synthesis, and degradation. Here, I summarize the current knowledge regarding IGF2 expression and functions in the brain, particularly in memory, and propose a novel conceptual model for IGF2/IGF2R mechanisms of action in brain health and diseases.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>37031050</pmid><doi>10.1016/j.tins.2023.03.007</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0001-7386-0018</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0166-2236
ispartof Trends in neurosciences (Regular ed.), 2023-06, Vol.46 (6), p.488-502
issn 0166-2236
1878-108X
language eng
recordid cdi_proquest_miscellaneous_2798713423
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Alzheimer Disease
Animals
Brain - metabolism
cation-independent mannose 6 phosphate receptor
Humans
IGF2 receptor
memory
neurodegenerative disease
Neurodegenerative Diseases - metabolism
neurodevelopmental disorder
Neurodevelopmental Disorders
Parkinson Disease
protein metabolism
title IGF2 in memory, neurodevelopmental disorders, and neurodegenerative diseases
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T08%3A55%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=IGF2%20in%20memory,%20neurodevelopmental%20disorders,%20and%20neurodegenerative%20diseases&rft.jtitle=Trends%20in%20neurosciences%20(Regular%20ed.)&rft.au=Alberini,%20Cristina%20M.&rft.date=2023-06&rft.volume=46&rft.issue=6&rft.spage=488&rft.epage=502&rft.pages=488-502&rft.issn=0166-2236&rft.eissn=1878-108X&rft_id=info:doi/10.1016/j.tins.2023.03.007&rft_dat=%3Cproquest_cross%3E2798713423%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2798713423&rft_id=info:pmid/37031050&rft_els_id=S0166223623000693&rfr_iscdi=true